CK

Chandra Kushwaha

Active Director Director DIN 07421710
DIN 07421710 First appointment Mar 2016 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2016
Shareholding value •••• Premium profile

About Chandra Kushwaha

Data last updated:

Chandra Kushwaha is a Director at Eremedium Private Limited (since 2016). The company operates in Healthcare. Eremedium Private Limited reported revenue of ₹4.40 Cr (FY 2024).

DIN 07421710
Primary Designation Director
Industry Healthcare
First Appointment 08 Mar 2016
Oldest Company Age 10 yrs
Largest company Eremedium Private Limited · ₹4.40 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eremedium Private Limited U72300UP2016PTC077034
Director08 Mar 20162016₹4.40 Cr (FY 2024)Active

Board colleagues of Chandra Kushwaha

Directorship timeline

Open interactive timeline →
Eremedium Private Limited
Premium access

Shareholding and investment profile for Chandra Kushwaha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandra Kushwaha

Chandra Kushwaha currently holds 1 directorship: Eremedium Private Limited (Director, since 08 Mar 2016, revenue ₹4.40 Cr (FY 2024)).

Chandra Kushwaha was first appointed on 08 Mar 2016 as Director at Eremedium Private Limited.

The current boards of Chandra Kushwaha's companies include Atma Ram Bansal (Eremedium Private Limited), Mohanish Singh (Eremedium Private Limited), Vinod Kumar (Eremedium Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available